Parkinson's News Today Home | Parkinson's News Today
WEBExtended-release Parkinson’s therapy Crexont available in US. Crexont, an extended-release formulation of levodopa and carbidopa, is now available in pharmacies across the U.S. for people with Parkinson’s disease.
A Potential Parkinson’s Treatment Has Promising Results
WEBJun 20, 2024 — A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment...
Q&A: New tech could improve care for Parkinson's patients
WEB2 days ago — The number of people living with Parkinson's disease globally has doubled in the past 25 years. Yet the treatment and monitoring of the neurological disease seems many decades behind. Clinicians ...
New Parkinson’s Treatments in the Clinical Trial Pipeline for 2024
WEBSep 26, 2023 — Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
Parkinson's vaccine seen to target toxic protein in Phase 1 trial
WEBMar 11, 2024 — Treatment with UB-312, a vaccine designed to trigger an immune response against toxic clumps of the alpha-synuclein protein, reduced these damaging aggregations in people with Parkinson’s disease in a Phase 1 trial.
New Vaccine for Parkinson’s Moves Closer to 1st Human Trials
WEBDec 1, 2022 — An experimental vaccine that stimulates immune responses against three regions of the alpha-synuclein protein — whose toxic clumps contribute to Parkinson’s disease and dementia with Lewy bodies (DLB) — is moving into late-stage preclinical research aimed at supporting future requests to test it in clinical trials.
Parkinson's disease - Latest research and news - Nature
WEB6 days ago — Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms...
New Findings About Key Pathological Protein in Parkinson’s …
WEBDec 18, 2023 — A so-called pathological protein long associated with Parkinson’s disease has been found in a new study to trigger cells to increase protein synthesis, an event that eventually kills the subset of brain cells that die off in this neurodegenerative condition.
New therapeutic target for Parkinson’s disease discovered
WEBJul 19, 2023 — Northwestern Medicine scientists have uncovered a new mechanism by which mutations in a gene parkin contribute to familial forms of Parkinson's disease. The discovery opens a new avenue for Parkinson’s therapeutics, scientists report in …
Revolutionizing the treatment of Parkinson's patients
WEBThe future treatment of Parkinson’s Disease has undergone tremendous development in recent years. Now, a breakthrough in research has emerged, delivering the strongest results for both...